Prescription Drug Resources


WHY PRESCRIPTION DRUGS?

The astounding rise of prescription drug prices — now approaching 20% of health care costs in the U.S. — has left employers and consumers reeling.

Employers are struggling to offer benefits that ensure access to common drugs like insulin with prices that have tripled over the past decade, and to life-saving new drug therapies for uncommon or rare conditions that typically range from $250,000 to $1 million. A drug approved by the FDA in late 2019 tops $2 million. And about 25% of adults say it is difficult to afford their medication, including one in 10 who say it is very difficult.


OUR FOCUS AND GOAL

Action Group members are committed to helping bring order to a dysfunctional prescription drug marketplace that is subject to high cost, high variability, and high waste. They have formed invaluable relationships with supply chain stakeholders who come to a common table to clarify purchaser expectations and to hold one another accountable for getting the 5 rights, right. The goals include:


TOOLS FOR EMPLOYERS

Given the right tools and resources, employers have the power to gain control over unpredictable and unsustainable prescription drug prices.


WORKING TOGETHER TO DRIVE CHANGE

The Action Group has convened Community Dialogues, member Learning Networks, and a Specialty Drug Guiding Coalition to collaborate with all prescription drug stakeholders and renowned expert advisors to drive policies and innovations that advance quality, value and transparency.


RELEVANT RESEARCH AND REPORTS

The work of Action Group members on addressing the high cost of prescription drugs is informed by relevant research.


ARTICLES AND MEDIA COVERAGE OF PRESCRIPTION DRUGS 


PASSIONATE ABOUT PRESCRIPTION DRUG REFORM?

If you are interested in engaging with The Action Group to drive improvements in the prescription drug marketplace, please contact Mamie Segall (msegall@mnhealthactiongroup.org).